Latest News about EXEL
Recent news which mentions EXEL
From Motley Fool
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
April 05, 2023
From Motley Fool
From Benzinga
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
April 05, 2023
From Benzinga
3 Beaten-Down Stocks That Could Soar This Year
March 18, 2023
From Motley Fool
From InvestorPlace
From Motley Fool
2 Stocks to Buy With Less Than $20
March 10, 2023
From Motley Fool
From Benzinga
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
From Benzinga
US Stocks Look To Snap String Of Weekly Losses As Futures Signal Positive Start Ahead Of Service Sector Data, Fed Speeches
March 03, 2023
From Benzinga
Dell, Zscaler, Marvell Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
March 03, 2023
From Benzinga
Nasdaq Bear Market: 5 Magnificent Growth Stocks You'll Regret Not Buying on the Dip
February 18, 2023
From Motley Fool
Bristol Myers Squibb-Exelixis Highlight Three-Year Follow Up Data From Opdivo+Cabometyx Combo Therapy In Kidney Cancer
February 14, 2023
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
February 14, 2023
From Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
February 12, 2023
From Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less Than $25
February 04, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.